Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00000256 · ClinicalTrials.gov registry record · NA

Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8

A NA study of Substance-Related Disorders and Opioid-Related Disorders, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT00000256 is a NA study of Substance-Related Disorders and Opioid-Related Disorders that has completed, run by University of Chicago. The registered enrollment target is 11 participants, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00000256, a NA study of Substance-Related Disorders and Opioid-Related Disorders, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiates, and benzodiazepine antagonists will be made. To examine reinforcing effects of brief exposures to nitrous oxide in healthy volunteers.

Interventions

  • DRUG 40% N2O
  • DRUG 20% N2O
  • DRUG 60% N2O
  • DRUG 80% N2O

Study Locations (1)

Illinois

  • University of Chicago, Anesthesia & Critical Care - Chicago

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 1995-08
Est. Completion 1996-11
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT00000256

The ClinicalTrials.gov registry entry for NCT00000256 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (99% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Substance-Related Disorders appearing as the primary indexed condition, and to 4 interventions - of which 40% N2O is the first listed.

NCT00000256 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT00000256 about?

NCT00000256 is a clinical study titled "Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8". The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. Comparisons between nitrous oxide, opiate...

What is the current status of trial NCT00000256?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 1995-08. Estimated completion is 1996-11.

What conditions does trial NCT00000256 study?

This clinical trial studies the following conditions: Substance-Related Disorders, Opioid-Related Disorders.

What interventions are being tested in trial NCT00000256?

The interventions under investigation include: 40% N2O (DRUG), 20% N2O (DRUG), 60% N2O (DRUG), 80% N2O (DRUG).

Who is sponsoring clinical trial NCT00000256?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00000256 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.